1) Holding Ahead of Apple US markets entered a holding pattern ahead of Apple’s (AAPL) earnings report, which hit after the close today. (more on this below) The S&P 500 traded in an extremely tight range today before finishing at 2169.19, up a tiny 0.03% on the day. The Nasdaq and Russell 2000 indices showed solid outperformance today despite an intraday drop in oil and some biotech names. This was a bit of a surprise given that overseas markets indicated a risk-off posture in the early going, perhaps best exemplified by the sharp rise in the Japanese yen, which rallies when traders grow more cautious. Crude oil stayed weak, with WTI crude breaking the $43 handle, though energy stocks actually finished up. 2) Bio-Confusion Large cap biotechnology stocks took a tumble today after industry giant Gilead (GILD) reported disappointing second-quarter earnings results and poor guidance. Gilead, which accounts for 8% of the iShares Nasdaq Biotechnology ETF (IBB), fell -8.5% today, while IBB dipped -0.7% That wasn’t exactly a pretty picture, but outside of Gilead, biotechnology was actually pretty decent. The XBI ETF, which is much more diversified than IBB, was actually well in the green today. This indicates that many traders believe Gilead is facing company-specific problems that won’t impact the sector. 3) Post-Close Earnings Twitter (TWTR) beat analysts’ earnings estimates for the 6th quarter in a row, but it reported disappointing revenues and delivered atrocious third-quarter guidance. Many traders were surprised at Twitter’s dissappointment given the headline-heavy US election cycle and global geopolitical troubles, which should be driving significant news consumption and chatter via Twitter. Twitter shares were down sharply in extended trading. That’s not a surprise given that the stock just rose over 20% on takeover speculation. Meanwhile, Apple (AAPL) was up over 5% after-hours as the company beat Wall Street’s expectations for sales, earnings, and iPhone unit sales. Apple also offered strong forward guidance. This should mean good things for the Apple calendar spread trade I suggested today. And it may even be good for the Intel (INTC) calendar spread trade from last week if tech stocks get a lift.
Continue Reading -->
Tech superheavyweight Apple (AAPL) reports earnings after the close today, and as always it’s the talk of the town for tech investors. Here is a quick summary of Wall Street’s consensus expectations: (data from Bloomberg and Factset) Sales: $42.0559B (Apple’s guidance was $42 billion) Earnings $1.386 per share Gross margin: 37.945% (guidance was 37.750%) iPhone units: ~40 million And for next quarter, analysts expect: Sales: $45.537B Earnings $1.593 per share Gross margin: 38.361% Now, let’s take a broader look at overall expectations for Apple. Right now, 82.7% of analysts rate it a buy. Let’s compare that to other major large-cap tech names: Facebook (FB): 88.0% rate it a buy Google (GOOGL): 90% Salesforce.com (CRM): 91.3% IBM (IBM): 25.9% Oracle (ORCL): 56.1% The average target price on Apple is now $121.91, down from $150+ last November. And for the full year, analysts now expect revenues of $215 billion, down from nearly $250 billion last fall. You can see the trend in this chart: (red is 2016 revenue expectations, white is stock price) So it’s safe to say that expectations have come down quite a bit. And perhaps most tellingly, yesterday, BGC analyst Collin Gillis downgraded the stock to a sell, saying “Our opinion [is] that Apple has peaked under the leadership of CEO Tim Cook.” That’s not as dramatic as the “Fire Tim Cook Era” which marked the last major Apple bottom: But it’s certainly in the same ballpark in terms of line of thinking. Remember, Apple is very cyclical at this point, and you want to buy when the news stinks. Therefore, I think the bulls have the edge with Apple here. Even if Apple misses, the downside may be limited because a decent amount of negativity is being priced in with the stock trading at 11 times earnings with a 2.2% dividend yield. (vs. a 10-year Treasury with a 1.56% yield) I’ll be back after the open with some possible options trades. (Click here for my trade idea)
Continue Reading -->
The yen is rising this morning on what looks like an advance “sell the news” reaction in advance of the Bank of Japan Meeting on July 28-29. Remember, the yen has been ripping all year: Most economists expect the bank to increase its ETF purchase prices, cut rates, and increase its JGB purchases, which could mean it’s all but priced in. The Nikkei is off -1.4% and most European markets are red. SPX futures are flat, and I’m surprised they’re not down more. Crude oil slumped under $43 and the key biotech sector is getting roughed up in the early going. Gilead (GILD), which is 8.1% off the IBB ETF, is taking a big hit on its disappointing earnings reports, and is off 4.3% in the early going. IBB is indicated down -0.9%. That’s not the end of the world, but we can all agree that things are just plain better when biotech keeps its act together. There have been 4 horsemen leading equities since the 2/11 low — biotech (IBB), oil, high-yield (HYG), and the Russell 2000. Biotech and oil are obviously feeling the heat. High-yield is closely linked to oil (since oil prices drive default rates on energy bonds). Here is a chart of the HYG ETF vs. crude oil over the past year: So we have 3 of the 4 in some kind of trouble. Therefore, keep your eyes on the Russell. If that starts giving up, maybe the bears will score a victory. Post-Brexit, they haven’t been been able to do much. I still see an April-May-style sideways grind for the time being. Markets are a little stretched and sentiment is positive, but you can’t argue with price. Frankly, with the yen up so much and oil now 15%+ from the high , I expected SPX futures to be down at a least a half-percent. But they’re flat. In other earnings news, industrial giant United Technologies (UTX) is up after beating. The economic calendar picks up a little bit today, with S&P Case-Shiller, Markit PMI, Consumer Confidence, Richmond Fed, and New Home Sales numbers coming. However, the big news comes after the close with Apple’s (AAPL) earnings report. Expectations appear to be pretty low, but remember, it takes a lot of money to move Apple, so they really need to deliver. Twitter’s (TWTR) also reporting, and given how much that stock has run since Microsoft (MSFT) bought LinkedIn (LNKD), it will be in close focus. Still not fan of that one. Good luck friends!
Continue Reading -->